SCHEMBL4894901

SCHEMBL4894901

CCOC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3CN(C)C)cc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 4/20 0.42
LMNA P02545 3/20 0.37
GAA P10253 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 4/20 0.36
MAPK1 P28482 2/20 0.35
MCL1 Q07820 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.35
PABPC1 P11940 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX5 P09917 2/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
MLNR O43193 1/20 0.34
NR1I2 O75469 1/20 0.34
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14067541 0.93 ALDH1A1 (0.45) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL4905967 0.93 KDM4E (0.41) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL4927680 0.92 ALDH1A1 (0.41) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL4906165 0.91 ALDH1A1 (0.39) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL14076857 0.90 ALDH1A1 (0.43) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL4906060 0.90 ALDH1A1 (0.40) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4660296 0.90 LMNA (0.36) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL4591362 0.88 MEN1 (0.34) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4903775 0.88 ALDH1A1 (0.41) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL14067512 0.88 ALDH1A1 (0.41) KDM4EALDH1A1LMNAGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214527-A1 Hiv Integrase Inhibitors API5, ING2, SAMHD1 KDM4E 1139/4885ALDH1A1 2874/4885LMNA 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.